Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)
| 8.87 Data as of 1:02pm ET |  -0.02 / -0.22%Today’s Change | 2.55 Today|||52-Week Range 30.00 | -9.03% Year-to-Date |
Latest IMMY News | Press Releases
No recent news for Imprimis Pharmaceuticals Inc.
Today’s Trading
| Previous close | 8.89 |
| Today’s open | 8.89 |
| Day’s range | 8.80 - 8.89 |
| Volume | 14,800 |
| Average volume (3 months) | 28,717 |
| Market cap | $79.0M |
| Dividend yield | -- |
Data as of 1:02pm ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | +55.71% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 404.42 |
| Price/Book | 6.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MDGNMedgenics Inc | -0.07 | -1.67% |
| DRRXDURECT Corp | +0.05 | +5.57% |
| OGENOragenics Inc | -0.07 | -2.32% |
| ZLCSZalicus Inc | +0.02 | +3.45% |
Data as of 1:44pm ET, 05/21/2013
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $100.0K |
| Annual profit (last year) | -$5.4M |
| Net profit margin | -5,383.54% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer, Secretary & Director Mark L. Baum |
President Balbir Brar, PhD |
Corporate headquarters Solana Beach, California |
Forecasts
